Size-exclusion chromatographic reconstitution of the bovine brain benzodiazepine receptor. Effects of lipid environment on the binding characteristics

Journal of Chromatography A

Volumn 776, Issue 1, 1997, Pages 101-107

  Viel, Gerhard T ^a   Yang, Qing ^b   Lundahl, Per ^c   Ensing, Kees ^a   De Zeeuw, Rokus A ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Benzodiazepine receptors; Proteins; Proteoliposomes; Solubilization

Indexed keywords

BENZODIAZEPINE RECEPTOR; FLUNITRAZEPAM;

ANIMAL TISSUE; BINDING AFFINITY; BINDING SITE; BRAIN; CATTLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FREEZING; GEL PERMEATION CHROMATOGRAPHY; IN VITRO STUDY; LIPID COMPOSITION; NONHUMAN; PRIORITY JOURNAL; PROTEOLIPOSOME; RECEPTOR SOLUBILIZATION; STORAGE; TECHNIQUE; THAWING;

ANIMALS; BRAIN CHEMISTRY; CATTLE; CHROMATOGRAPHY, GEL; DEOXYCHOLIC ACID; DETERGENTS; FLUNITRAZEPAM; FREEZING; GABA MODULATORS; LIPIDS; LIPOSOMES; PROTEIN BINDING; RECEPTORS, GABA-A; SERUM ALBUMIN, BOVINE;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0030812477     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9673(97)00428-7     Document Type: Conference Paper

References (25)

1. Lang B., Barnard E.A., Chang L.-R., Dolly J.O. FEBS Lett. 104:1979;149.
2. Hammond J.R., Martin I.L. J. Neurochem. 47:1986;1161.
3. Asano T., Ogasawara N. Life Sci. 26:1980;607.
4. Asano T., Ogasawara N. Life Sci. 29:1981;193.
5. Stephenson F.A., Olsen R.W. J. Neurochem. 39:1982;1579.
6. Schoch P., Häring P., Takacs B., Stähli C., Möhler H. J. Recept. Res. 4:1984;189.
7. Sigel E., Mamalaki C., Barnard E.A. Neurosci. Lett. 61:1985;165.
8. Hirouchi M., Taguchi J., Ueha T., Kuriyarna K. Biochem. Biophys. Res. Commun. 146:1987;1471.
9. Scheideler M.A., Zukin R.S. J. Biol. Chem. 265:1990;15176.
10. Dunn S.M.J., Martin C.R., Agey M.W., Miyazaki R. Biochemistry. 28:1989;2545.
11. Lund J. Scand. J. Clin. Lab. Invest. 41:1981;275.
12. S. Clark, in: J.C. Venter, L.C. Harrison (Eds.), Receptor Purification Procedures, Alan R. Liss, New York, 1984, p. 149.
13. Bensadoun A., Weinstein D. Anal. Biochem. 70:1976;241.
14. Bartlett G.R. J. Biol. Chem. 234:1959;466.
15. Brunner J., Skrabal P., Hauser H. Biochim. Biophys. Acta. 455:1976;322.
16. Lundahl P., Yang Q. J. Chromatogr. 544:1991;283.
17. Brekkan E., Lundqvist A., Lundahl P. Biochemistry. 35:1996;12141.
18. Munson P.J., Rodbard D. Anal. Biochem. 107:1980;220.
19. Pick U. Arch. Biochem. Biophys. 212:1981;186.
20. R.C. MacDonald, R.I MacDonald, in: G. Gregoriadis (Ed.), Liposome Technology, CRC Press, Boca Raton, FL, 1993, p. 209.
21. E. Brekkan, Q. Yang, G. Viel, P. Lundahl, in G. Bickerstaff (Ed.), Methods in Molecular Biotechnology, Vol. 1: Immobilization of Enzymes and Cells, Humana Press, Clifton, NJ, 1996, p. 193.
22. M.J. Janssen, K. Ensing and R.A de Zeeuw, Preparative Biochem., in press.
23. Janssen M.J., Stegeman M., Ensing K., de Zeeuw R.A. J. Pharm. Biomed. Anal. 14:1996;989.
24. Hammond J.R., Martin I.L. Eur. J. Pharmacol. 137:1987;49.
25. Moynagh P.N., Williams D.C. Biochem. Pharmacol. 43:1992;1939.